Dr Martin Makary

News

Scrabble lettering of Two and One on grass

Makary says FDA will "end two-trial dogma" for approvals

The FDA plans to adopt a new policy that will do away with the default requirement to base regulatory filings for new medicines on two pivotal trials.

News

Antibiotic is first approval in FDA national priority scheme

FDA approves its first 'national priority' drug – a version of the widely used antibiotic Augmentin XR – in double-quick time.

News

GLP-1s feature in second batch of national priority vouchers

GLP-1 drugs for weight loss, cancer, and rare diseases feature among the latest crop of medicines awarded priority vouchers by the FDA.

News

FDA hands out first national priority vouchers to nine firms

The FDA has named the first products to take advantage of its recently announced Commissioner's national priority voucher programme.

News

FDA will review abortion pill safety – will it be impartial?

The Trump administration's linking of autism to Tylenol and vaccines with no evidence raises concern about an FDA review of mifepristone's safety.

News

Vinay Prasad returns to FDA

In a new spin on the concept of the FDA's 'revolving door', Vinay Prasad is back as head of CBER, just over a week after leaving the role.

Makary says FDA will "end two-trial dogma" for approvals

Antibiotic is first approval in FDA national priority scheme

GLP-1s feature in second batch of national priority vouchers

FDA hands out first national priority vouchers to nine firms

FDA will review abortion pill safety – will it be impartial?

Vinay Prasad returns to FDA

Lilly inflates US facility investment spending by $4.5bn

Discover a new era of healthcare panel engagement: Grounded ...

Dr Martin Makary

Editor's Picks